(Q31014821)

28 June 2017

1 reference

title

The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies (English)

1 reference

28 June 2017

0 references

0 references

AIDS dementia complex

1 reference

Navia BA

1

1 reference

PubMed ID

16260383

28 June 2017

Rostasy K

series ordinal

2

1 reference

28 June 2017

1 October 2005

1 reference

28 June 2017

Neurotoxicity Research

1 reference

28 June 2017

8

1 reference

28 June 2017

1-2

1 reference

28 June 2017

3-24

1 reference

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

28 June 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Memantine prevents HIV coat protein-induced neuronal injury in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

A phase I/II trial of nimodipine for HIV-related neurologic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Increased cerebral blood volume in HIV-positive patients detected by functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Mild cognitive impairment and risk of mortality in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033817

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

21 January 2018

1 reference

12 December 2020

Whole brain diffusion tensor imaging in HIV-associated cognitive impairment

1 reference

12 December 2020

HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism

1 reference

12 December 2020

CSF, plasma viral load and HIV associated dementia

1 reference

12 December 2020

Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS

1 reference

12 December 2020

Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

1 reference

12 December 2020

The neuropsychological aspects of HIV-1 spectrum disease

1 reference

12 December 2020

Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1-infected brain

1 reference

12 December 2020

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

12 December 2020

Clinical-neuropathologic correlation in HIV-associated dementia

1 reference

12 December 2020

Human immunodeficiency virus-associated dementia: an evolving disease

1 reference

12 December 2020

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

12 December 2020

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

1 reference

12 December 2020

Unique monocyte subset in patients with AIDS dementia

1 reference

12 December 2020

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy

1 reference

12 December 2020

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

1 reference

12 December 2020

Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events

1 reference

12 December 2020

HIV leucoencephalopathy and TNFalpha expression in neurones

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome

1 reference

12 December 2020

Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

1 reference

12 December 2020

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

1 reference

12 December 2020

Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1

1 reference

12 December 2020

Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.

1 reference

12 December 2020

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

12 December 2020

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

12 December 2020

Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients

1 reference

12 December 2020

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

1 reference

12 December 2020

Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

1 reference

12 December 2020

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.

1 reference

12 December 2020

Antiretroviral drugs and the central nervous system.

1 reference

12 December 2020

Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment

1 reference

12 December 2020

Neuropsychological characterization of the AIDS dementia complex: a preliminary report.

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

1 reference

12 December 2020

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients

1 reference

12 December 2020

Regional patterns of brain metabolites in AIDS dementia complex

1 reference

12 December 2020

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

12 December 2020

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Evidence of apoptotic cell death in HIV encephalitis

1 reference

12 December 2020

Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis.

1 reference

12 December 2020

Information processing and antiretroviral therapy in HIV-1 infection.

1 reference

12 December 2020

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

12 December 2020

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

12 December 2020

The metabolic pathology of the AIDS dementia complex

1 reference

12 December 2020

Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia

1 reference

12 December 2020

Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia

1 reference

12 December 2020

NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex.

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

1 reference

12 December 2020

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences

1 reference

12 December 2020

Production and neuroprotective functions of fractalkine in the central nervous system.

1 reference

12 December 2020

Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex

1 reference

12 December 2020

Neurocognitive and psychological contributions to quality of life in HIV-1-infected women.

1 reference

12 December 2020

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases

1 reference

12 December 2020

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

1 reference

12 December 2020

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons

1 reference

12 December 2020

Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia

1 reference

12 December 2020

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

12 December 2020

The AIDS dementia complex: II. Neuropathology.

1 reference

12 December 2020

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

1 reference

12 December 2020

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia

1 reference

12 December 2020

The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha.

1 reference

12 December 2020

Drug treatment for HIV-1-associated dementia.

1 reference

12 December 2020

Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.

1 reference

12 December 2020

Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes

1 reference

12 December 2020

Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis.

1 reference

12 December 2020

AIDS dementia complex: evaluation with proton MR spectroscopic imaging

1 reference

12 December 2020

Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro

1 reference

12 December 2020

A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection

1 reference

12 December 2020

Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

1 reference

12 December 2020

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

1 reference

12 December 2020

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

12 December 2020

HIV antigen in the brains of patients with the AIDS dementia complex

1 reference

12 December 2020

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

1 reference

12 December 2020

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

12 December 2020

Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults

1 reference

12 December 2020

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

1 reference

12 December 2020

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes

1 reference

12 December 2020

CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity

1 reference

12 December 2020

Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4.

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

Neocortical damage during HIV infection

1 reference

12 December 2020

Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis.

1 reference

12 December 2020

Memantine in moderate-to-severe Alzheimer's disease

1 reference

12 December 2020

Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.

1 reference

12 December 2020

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

1 reference

12 December 2020

HIV type 1 V3 sequences and the development of dementia during AIDS.

1 reference

12 December 2020

Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin

1 reference

12 December 2020

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

12 December 2020

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

1 reference

12 December 2020

In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS.

1 reference

12 December 2020

Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia

1 reference

12 December 2020

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

12 December 2020

Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury.

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis

1 reference

12 December 2020

Roles of nuclear factor kappaB in neuronal survival and plasticity

1 reference

12 December 2020

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

Evaluation of the AIDS dementia complex in clinical trials

1 reference

12 December 2020

Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis

1 reference

12 December 2020

Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1.

1 reference

12 December 2020

Insights into the role of immune activation in HIV neuropathogenesis

1 reference

12 December 2020

Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis

1 reference

12 December 2020

Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells

1 reference

12 December 2020

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

1 reference

12 December 2020

Management of the neurologic complications of HIV infection and AIDS.

1 reference

12 December 2020

Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.

1 reference

12 December 2020

Localized cerebral proton MR spectroscopy in HIV infection and AIDS.

1 reference

12 December 2020

N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals

1 reference

12 December 2020

Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy.

1 reference

12 December 2020

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage

1 reference

12 December 2020

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis

1 reference

12 December 2020

Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy

1 reference

12 December 2020

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

1 reference

12 December 2020

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

1 reference

12 December 2020

A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia

1 reference

12 December 2020

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

12 December 2020

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

12 December 2020

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

1 reference

12 December 2020

Apoptosis induced by HIV-1 infection of the central nervous system

1 reference

12 December 2020

Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy

1 reference

12 December 2020

Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033817

1 reference

PubMed ID

16260383

Dimensions Publication ID

28 June 2017

0 references

1 reference

PubMed ID

16260383